| 摘要 |
The present invention relates to a pharmaceutical or veterinary or nutritional or personal care composition comprising coenzyme Q<SUB>10</SUB> (CoQ<SUB>I0</SUB>), reduced CoQ<SUB>1O</SUB>, or mixtures thereof and oxygenated dibenzo-a-pyrone or an amino acyl ester thereof. The composition of the present invention is able to support and/or provide therapy to individuals at risk and/or under treatment for dysfunctions of energy metabolism, and specifically, for mitochondrial diseases. |
